Patterns of Fatigue in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs

被引：0
|
作者：
Freites Nunez, Dalifer [1 ]
Leon, Leticia [2 ]
Redondo, Marta [3 ]
Vadillo Font, Cristina [1 ]
Lois, Pia [1 ]
Mucientes Ruiz, Arkaitz [1 ]
Rodriguez-Rodriguez, Luis [2 ]
Fernandez Gutierrez, Benjamin [1 ]
Jover Jover, Juan Angel [1 ]
Abasolo Alcazar, Lydia [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
[2] Fdn Invest Biomed, Madrid, Spain
[3] Univ Camilo Jose Ceja, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1334
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Healthcare resource utilisation and economic burden of patients with adequate and inadequate responses to biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis in Japan
    Ikeda, Kei
    Kaneko, Yuko
    Tsujita, Yuki
    Kawaguchi, Isao
    Patel, Jayeshkumar
    Yamazaki, Toru
    Fang, Siran
    Kawahito, Yutaka
    MODERN RHEUMATOLOGY, 2023, 34 (05) : 910 - 917
  • [42] PARTICULARITIES OF TREATMENT WITH CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs) IN A GROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Schiotis, Ruxandra Elena
    Gosa, Dana
    Bocsan, Corina
    Suciu, Soimita
    Buzoianu, Anca Dana
    FARMACIA, 2017, 65 (03) : 479 - 484
  • [43] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARD) IN THE TREATMENT OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    HALBERG, P
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1986, : 55 - 57
  • [44] Effects of Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Response to Periodontal Treatment in Patients with Rheumatoid Arthritis
    Jung, Gyu-Un
    Han, Ji-Young
    Hwang, Kyung-Gyun
    Park, Chang-Joo
    Stathopoulou, Panagiota G.
    Fiorellini, Joseph P.
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [45] Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
    Xia, Yunfei
    Yin, Rulan
    Fu, Ting
    Zhang, Lijuan
    Zhang, Qiuxiang
    Guo, Genkai
    Li, Liren
    Gu, Zhifeng
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 735 - 742
  • [46] Disease-modifying antirheumatic drugs in rheumatoid arthritis patients with a history of colorectal cancer
    Kleinert, S.
    Waldner, M.
    Wendler, J.
    Kunzmann, V.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (01): : 41 - 46
  • [47] High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Rauscher, Veronika
    Englbrecht, Matthias
    van der Heijde, Desiree
    Schett, Georg
    Hueber, Axel J.
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (03) : 386 - 390
  • [48] Risk of severe COVID-19 in patients on biological and targeted synthetic disease-modifying antirheumatic drugs
    Ralston, Stuart H.
    Porter, Duncan
    Hollick, Rosemary
    McAllister, David
    Colhoun, Helen
    McKiegue, Paul
    SCOTTISH MEDICAL JOURNAL, 2022, 67 (01) : 52 - 53
  • [49] Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance
    Alla Ishchenko
    Rik J. Lories
    Drugs & Aging, 2016, 33 : 387 - 398
  • [50] Risk of malignant lymphoma in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs and methotrexate
    Inose, Ryo
    Hosomi, Kouichi
    Takahashi, Katsuyuki
    Yokoyama, Satoshi
    Takada, Mitsutaka
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (02) : 63 - 72
12345